EAM
Erste Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.7M | Buy |
1,621,415
+560,350
| +53% | +$9.58M | 0.23% | 98 |
|
|
2025
Q1 | $62.8M | Buy |
1,061,065
+352,817
| +50% | +$20.9M | 0.81% | 31 |
|
|
2024
Q4 | $76M | Buy |
708,248
+72,183
| +11% | +$7.74M | 0.93% | 22 |
|
|
2024
Q3 | $79.4M | Buy |
636,065
+114,665
| +22% | +$14.3M | 0.95% | 20 |
|
|
2024
Q2 | $82.4M | Sell |
521,400
-50,000
| -9% | -$7.9M | 1.09% | 16 |
|
|
2024
Q1 | $74M | Sell |
571,400
-130,000
| -19% | -$16.8M | 1.01% | 17 |
|
|
2023
Q4 | $67.7M | Buy |
701,400
+16,000
| +2% | +$1.54M | 0.99% | 20 |
|
|
2023
Q3 | $83.2M | Sell |
685,400
-35,460
| -5% | -$4.3M | 1.43% | 9 |
|
|
2023
Q2 | $82.3M | Buy |
720,860
+72,000
| +11% | +$8.22M | 1.45% | 7 |
|
|
2023
Q1 | $89.3M | Buy |
648,860
+34,460
| +6% | +$4.74M | 1.71% | 4 |
|
|
2022
Q4 | $79.5M | Sell |
614,400
-57,460
| -9% | -$7.44M | 1.68% | 4 |
|
|
2022
Q3 | $74.2M | Sell |
671,860
-107,000
| -14% | -$11.8M | 1.66% | 4 |
|
|
2022
Q2 | $58.6M | Hold |
778,860
| – | – | 1.3% | 7 |
|
|
2022
Q1 | $60.9M | Sell |
778,860
-82,000
| -10% | -$6.41M | 1.16% | 7 |
|
|
2021
Q4 | $78M | Buy |
860,860
+7,800
| +0.9% | +$707K | 1.41% | 6 |
|
|
2021
Q3 | $78.8M | Buy |
853,060
+30,000
| +4% | +$2.77M | 1.56% | 6 |
|
|
2021
Q2 | $64M | Buy |
823,060
+181,500
| +28% | +$14.1M | 1.27% | 9 |
|
|
2021
Q1 | $47.8M | Buy |
641,560
+261,250
| +69% | +$19.5M | 1.17% | 16 |
|
|
2020
Q4 | $65.3M | Buy |
380,310
+7,950
| +2% | +$1.36M | 1.81% | 3 |
|
|
2020
Q3 | $52.4M | Sell |
372,360
-28,900
| -7% | -$4.06M | 1.79% | 3 |
|
|
2020
Q2 | $64.6M | Sell |
401,260
-25,000
| -6% | -$4.03M | 2.58% | 3 |
|
|
2020
Q1 | $41.8M | Sell |
426,260
-144,000
| -25% | -$14.1M | 2.43% | 2 |
|
|
2019
Q4 | $73.6M | Buy |
570,260
+21,600
| +4% | +$2.79M | 3.26% | 2 |
|
|
2019
Q3 | $41.3M | Buy |
548,660
+15,440
| +3% | +$1.16M | 2.2% | 2 |
|
|
2019
Q2 | $78.6M | Buy |
533,220
+10,100
| +2% | +$1.49M | 4.18% | 1 |
|
|
2019
Q1 | $62.3M | Buy |
523,120
+14,310
| +3% | +$1.7M | 3.49% | 3 |
|
|
2018
Q4 | $54.8M | Buy |
+508,810
| New | +$54.8M | 3.69% | 2 |
|